Four-membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors

A series of novel azaspirocycle or azetidine substituted 4-anilinoquinazoline derivatives were prepared and their EGFR inhibitory activities as well as in vitro antitumor potency were reported.